However, MGMT methylation status is also predictive of treatment response in IDH wild-type GBM patients (36) and abnormal methylation of MGMT has increased prognosis in some GBM patients after TMZ treatment (37) (Figure 1). The gene discussed is MGMT; the disease is glioblastoma.